UBS Group Issues Pessimistic Forecast for Certara (NASDAQ:CERT) Stock Price

Key Points

• UBS Group has reduced its price target for Certara's stock from $17.50 to $15.00, while maintaining a "buy" rating, indicating a potential upside of 34.29% from the stock's previous close.
• Certara's quarterly earnings showed a report of $0.07 EPS, missing the consensus estimate of $0.10, despite a year-over-year revenue increase of 12.1%.
• The stock currently has a consensus rating of "Moderate Buy" and a target price of $15.14, with several analysts providing varied ratings from "neutral" to "overweight".

Certara (NASDAQ:CERT - Get Free Report) had its price objective cut by stock analysts at UBS Group from $17.50 to $15.00 in a report released on Thursday,Benzinga reports. The firm presently has a "buy" rating on the stock. UBS Group's price objective points to a potential upside of 34.29% from the stock's previous close.

A number of other equities research analysts have also weighed in on the stock. Robert W. Baird boosted their price objective on shares of Certara from $9.00 to $13.00 and gave the company a "neutral" rating in a report on Friday, April 11th. KeyCorp cut their price objective on Certara from $18.00 to $15.00 and set an "overweight" rating on the stock in a report on Monday, July 14th. JMP Securities reaffirmed a "market perform" rating on shares of Certara in a report on Tuesday, May 6th. Barclays upgraded shares of Certara from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $11.00 to $14.00 in a report on Thursday, May 8th. Finally, Morgan Stanley initiated coverage on shares of Certara in a research note on Thursday, July 3rd. They set an "equal weight" rating and a $16.00 price objective for the company. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, Certara currently has a consensus rating of "Moderate Buy" and a consensus target price of $15.14.

Certara Trading Up 17.2%

CERT traded up $1.64 on Thursday, reaching $11.17. 2,096,565 shares of the company traded hands, compared to its average volume of 1,733,646. The company has a market cap of $1.81 billion, a P/E ratio of -558.95 and a beta of 1.42. The firm has a fifty day simple moving average of $10.94 and a two-hundred day simple moving average of $11.79. Certara has a one year low of $8.64 and a one year high of $15.69. The company has a quick ratio of 2.78, a current ratio of 2.78 and a debt-to-equity ratio of 0.27.

Certara (NASDAQ:CERT - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). Certara had a positive return on equity of 5.05% and a negative net margin of 0.67%. The business had revenue of $104.57 million during the quarter, compared to analysts' expectations of $104.14 million. During the same period in the previous year, the company posted $0.07 EPS. Certara's revenue for the quarter was up 12.1% on a year-over-year basis. As a group, equities research analysts expect that Certara will post 0.28 earnings per share for the current year.

Institutional Trading of Certara

Several institutional investors have recently bought and sold shares of CERT. ArrowMark Colorado Holdings LLC grew its stake in Certara by 164.2% in the 4th quarter. ArrowMark Colorado Holdings LLC now owns 6,213,278 shares of the company's stock valued at $66,171,000 after acquiring an additional 3,861,674 shares during the period. Geneva Capital Management LLC lifted its holdings in Certara by 7.8% in the 2nd quarter. Geneva Capital Management LLC now owns 6,114,895 shares of the company's stock valued at $71,544,000 after purchasing an additional 443,206 shares in the last quarter. Teacher Retirement System of Texas boosted its stake in Certara by 25.3% during the 2nd quarter. Teacher Retirement System of Texas now owns 5,674,485 shares of the company's stock worth $66,391,000 after purchasing an additional 1,145,554 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Certara by 13.6% during the first quarter. Ameriprise Financial Inc. now owns 4,295,566 shares of the company's stock worth $42,526,000 after buying an additional 515,911 shares in the last quarter. Finally, Mackenzie Financial Corp grew its holdings in shares of Certara by 7.0% during the first quarter. Mackenzie Financial Corp now owns 1,793,327 shares of the company's stock worth $17,754,000 after buying an additional 117,089 shares in the last quarter. 73.96% of the stock is owned by institutional investors and hedge funds.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.